Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.

This week's research roundup features: Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study.

Topic's Include: COVID-19 media only news briefing: managing influenza during a pandemic, Mayo Clinic Q and A: COVID-19 vaccine boosters and third doses, and COVID Queries: Delta breakthrough infections.

Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.

Topic's Include: Biden: 2.8M people signed up for ObamaCare in special period, the pandemic marks another grim milestone of 1 in 500 Americans die of COVID-19, and understanding the delta variant, vaccines and breakthrough cases in Minnesota.

In this episode of Lab Medicine Rounds, Dr. Marshall Mazepa, Assistant Professor of Medicine at the University of Minnesota, discusses the topic of thrombotic thrombocytopenic purpura (TTP) and why it’s important to understand it.

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update.

As a regulatory affairs coordinator in Quality Management Services, it’s Corrisa Miliander’s job to report diseases to each state across the country as required by law — a crucial role that supports public health agencies as they work to monitor and control outbreaks of communicable diseases.

Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for patients across a variety of specialities.

Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.

This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.

Topic's Include: Being vaccinated for COVID-19 means protection against more than severe illness, Vaccines to Variants, and COVID-19 variants mu, delta and what to know about mutations.